Pfizer Inc, struggling with fierce competition from makers of generic drugs, said it would cut 10,000 jobs and close at least five facilities as part of an effort to slash its annual costs by up to US$2 billion by the end of next year.
The drastic measures announced on Monday by the world's largest drug maker highlight the challenges faced by many pharmaceutical companies recently.
In addition to patent expirations, big drug companies are facing a business climate where insurers and other large purchasers of medicines are demanding lower prices and more evidence of products' worth.
Although big rounds of job cuts typically boost a company's stock prize, shares of Pfizer fell US$0.27, or 1 percent, to close on Monday at US$26.95 on the New York Stock Exchange.
It is the second time in two years the maker of Viagra and Lipitor has announced a major cost-reduction plan to combat the loss of about US$14 billion in revenues from 2005 to this year due to expiring patents.
The company is at risk of losing 41 percent of its sales to generic competition between 2010 and 2012, including the revenue from its top seller Lipitor, Prudential analyst Tim Anderson said.
The latest cuts come on top of a previously announced plan to slash costs by US$4 billion a year by next year. On Monday, Pfizer said it would cut an additional US$500 million to US$1 billion in costs. However, it said some of the savings would be redeployed into the company so the total savings would be between US$1.5 billion and US$2 billion a year.
The 10,000 layoffs amount to about 10 percent of the company's global work force and include the elimination of 2,200 jobs from the US sales force, which Pfizer announced late last year. The company said on Monday it would cut 20 percent of its European sales force but did not say how many jobs that will be.
Pfizer will close three research sites in Michigan and two manufacturing plants in New York and Nebraska. It may also sell another manufacturing site in Germany and close research sites in Japan and France.
Aside from outlining cuts, Pfizer also detailed how it would restructure its business in an effort to become more nimble and flexible. The US commercial business will be divided into five distinct units, each with a general manager responsible for that group's performance. Two research areas are being abandoned while other research and development efforts are being consolidated.
Pfizer also pledged to interact more with potential customers such as insurers to make sure it is developing medicines they deem worthy of purchasing.
"I believe we must transform the way we've done business in the past in order to be more successful in the future," said Jeffrey Kindler, who became Pfizer's CEO last summer and chairman last month. "Incremental evolution is not enough. Fundamental change is imperative -- and it must happen now," he said.
Pfizer reiterated that its revenue would be flat this year and next, but it expects earnings to jump between 6 percent and 9 percent this year and next year.
For the fourth quarter, Pfizer's net income soared to US$9.45 billion, or US$1.32 per share, from US$2.73 billion, or US$0.37 per share, a year ago. Excluding gains from the sale of its consumer health care business last month, earnings totaled US$3.05 billion, or US$0.43 per share, down from an adjusted US$3.59 billion, or US$0.49 a share, a year ago.
MORE VISITORS: The Tourism Administration said that it is seeing positive prospects in its efforts to expand the tourism market in North America and Europe Taiwan has been ranked as the cheapest place in the world to travel to this year, based on a list recommended by NerdWallet. The San Francisco-based personal finance company said that Taiwan topped the list of 16 nations it chose for budget travelers because US tourists do not need visas and travelers can easily have a good meal for less than US$10. A bus ride in Taipei costs just under US$0.50, while subway rides start at US$0.60, the firm said, adding that public transportation in Taiwan is easy to navigate. The firm also called Taiwan a “food lover’s paradise,” citing inexpensive breakfast stalls
TRADE: A mandatory declaration of origin for manufactured goods bound for the US is to take effect on May 7 to block China from exploiting Taiwan’s trade channels All products manufactured in Taiwan and exported to the US must include a signed declaration of origin starting on May 7, the Bureau of Foreign Trade announced yesterday. US President Donald Trump on April 2 imposed a 32 percent tariff on imports from Taiwan, but one week later announced a 90-day pause on its implementation. However, a universal 10 percent tariff was immediately applied to most imports from around the world. On April 12, the Trump administration further exempted computers, smartphones and semiconductors from the new tariffs. In response, President William Lai’s (賴清德) administration has introduced a series of countermeasures to support affected
CROSS-STRAIT: The vast majority of Taiwanese support maintaining the ‘status quo,’ while concern is rising about Beijing’s influence operations More than eight out of 10 Taiwanese reject Beijing’s “one country, two systems” framework for cross-strait relations, according to a survey released by the Mainland Affairs Council (MAC) on Thursday. The MAC’s latest quarterly survey found that 84.4 percent of respondents opposed Beijing’s “one country, two systems” formula for handling cross-strait relations — a figure consistent with past polling. Over the past three years, opposition to the framework has remained high, ranging from a low of 83.6 percent in April 2023 to a peak of 89.6 percent in April last year. In the most recent poll, 82.5 percent also rejected China’s
PLUGGING HOLES: The amendments would bring the legislation in line with systems found in other countries such as Japan and the US, Legislator Chen Kuan-ting said Democratic Progressive Party (DPP) Legislator Chen Kuan-ting (陳冠廷) has proposed amending national security legislation amid a spate of espionage cases. Potential gaps in security vetting procedures for personnel with access to sensitive information prompted him to propose the amendments, which would introduce changes to Article 14 of the Classified National Security Information Protection Act (國家機密保護法), Chen said yesterday. The proposal, which aims to enhance interagency vetting procedures and reduce the risk of classified information leaks, would establish a comprehensive security clearance system in Taiwan, he said. The amendment would require character and loyalty checks for civil servants and intelligence personnel prior to
RSS